Exercise training in Parkinson's disease: Neural and functional benefits

帕金森病的运动训练:对神经和功能的益处

基本信息

项目摘要

DESCRIPTION (provided by applicant): For individuals with Parkinson's disease (PD), symptoms such as tremor, rigidity, poor balance and difficulties in walking often limit their participation in physical activities. Such reductions in physical activity can accelerate aging-related degradations in motor control and therefore contribute to a spiraling decline in functional capacity that may eventually result in falls, loss of independence and or respiratory problems. Pharmacological treatment of PD can provide symptomatic relief during the early years, but is often less effective in the advanced stages of the disease and can often produce debilitating side effects. Moreover, there are no treatments currently available to stop or slow the progression of PD. Recent studies in animals have demonstrated that exercise training can result in favorable changes in brain function by increasing neurogenesis, neurotrophic factors and neuronal survival. Some human studies have indirectly supported this notion with observations of improved cognitive function and attention in people who participate in regular physical activity and who have higher cardiovascular fitness. Based on this and other research evidence, the long-term goal of this effort is to develop and optimize an exercise intervention that improves functional capacity in PD. This exploratory study will seek to establish that an exercise program for individuals with PD can provide improvements in functional outcomes and to investigate the changes in brain metabolism that may underlie such improvements. Future work will further characterize the adaptive brain mechanisms (neurogenesis, neurotrophism, and/or reversal of neurodegeneration) and optimize the exercise intervention. The specific aims of this project are: (1) to establish and deliver a readily-administered exercise therapy protocol to a group of individuals with PD, (2) to assess potential benefits using a battery of functional outcomes measures (balance, gait, rigidity, tremor, cardiorespiratory function, and cognitive task performance), and (3) to investigate the brain metabolic changes using FDG PET imaging that may underlie such benefits. Sixteen people with PD will participate in a 12-week polestriding (walking with poles) exercise program. While all the subjects will be evaluated for functional improvements, the changes in the brain metabolism will be evaluated only in eight subjects who will be randomly selected from a total of sixteen subjects. Subjects will undergo a battery of tests periodically at baseline (12 weeks prior to the intervention), pre-intervention, postintervention, and follow-up (12 weeks after completion of the exercise intervention). This study will provide a readily-administered intervention that can produce clinical benefits for individuals with PD. Furthermore, this initial investigation of exercise-induced changes in brain metabolism after PD will lay the foundation for follow-up studies to investigate and optimize exercise interventions to promote adaptation in the brain for treatment of PD. PUBLIC HEALTH RELEVANCE: Nearly 1% of people older than 65 years have been diagnosed with PD with a prevalence of 128 to 187 per 100,000 and an annual incidence of 20 per 100,000 in the United States. Recently, it has been suggested that long-term exercise training may substantially slow the neurodegenerative process and/or promote neuroadaptation in individuals with PD, which could significantly improve functional capabilities, increase independence, and reduce health care costs. If the proposed polestriding exercise training can result in anticipated improvements in functional outcomes and favorable changes in brain function, then regular practice of polestriding can be developed as a non-pharmacological therapy to alleviate symptoms of PD, to offset the aging-related decline in motor capabilities, and potentially to slow or reverse the disease progression.
DESCRIPTION (provided by applicant): For individuals with Parkinson's disease (PD), symptoms such as tremor, rigidity, poor balance and difficulties in walking often limit their participation in physical activities. Such reductions in physical activity can accelerate aging-related degradations in motor control and therefore contribute to a spiraling decline in functional capacity that may eventually result in falls, loss of independence and or respiratory problems. Pharmacological treatment of PD can provide symptomatic relief during the early years, but is often less effective in the advanced stages of the disease and can often produce debilitating side effects. Moreover, there are no treatments currently available to stop or slow the progression of PD. Recent studies in animals have demonstrated that exercise training can result in favorable changes in brain function by increasing neurogenesis, neurotrophic factors and neuronal survival. Some human studies have indirectly supported this notion with observations of improved cognitive function and attention in people who participate in regular physical activity and who have higher cardiovascular fitness. Based on this and other research evidence, the long-term goal of this effort is to develop and optimize an exercise intervention that improves functional capacity in PD. This exploratory study will seek to establish that an exercise program for individuals with PD can provide improvements in functional outcomes and to investigate the changes in brain metabolism that may underlie such improvements. Future work will further characterize the adaptive brain mechanisms (neurogenesis, neurotrophism, and/or reversal of neurodegeneration) and optimize the exercise intervention. The specific aims of this project are: (1) to establish and deliver a readily-administered exercise therapy protocol to a group of individuals with PD, (2) to assess potential benefits using a battery of functional outcomes measures (balance, gait, rigidity, tremor, cardiorespiratory function, and cognitive task performance), and (3) to investigate the brain metabolic changes using FDG PET imaging that may underlie such benefits. Sixteen people with PD will participate in a 12-week polestriding (walking with poles) exercise program. While all the subjects will be evaluated for functional improvements, the changes in the brain metabolism will be evaluated only in eight subjects who will be randomly selected from a total of sixteen subjects. Subjects will undergo a battery of tests periodically at baseline (12 weeks prior to the intervention), pre-intervention, postintervention, and follow-up (12 weeks after completion of the exercise intervention). This study will provide a readily-administered intervention that can produce clinical benefits for individuals with PD. Furthermore, this initial investigation of exercise-induced changes in brain metabolism after PD will lay the foundation for follow-up studies to investigate and optimize exercise interventions to promote adaptation in the brain for treatment of PD. PUBLIC HEALTH RELEVANCE: Nearly 1% of people older than 65 years have been diagnosed with PD with a prevalence of 128 to 187 per 100,000 and an annual incidence of 20 per 100,000 in the United States. Recently, it has been suggested that long-term exercise training may substantially slow the neurodegenerative process and/or promote neuroadaptation in individuals with PD, which could significantly improve functional capabilities, increase independence, and reduce health care costs. If the proposed polestriding exercise training can result in anticipated improvements in functional outcomes and favorable changes in brain function, then regular practice of polestriding can be developed as a non-pharmacological therapy to alleviate symptoms of PD, to offset the aging-related decline in motor capabilities, and potentially to slow or reverse the disease progression.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Narayanan Krishnamurthi其他文献

Narayanan Krishnamurthi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Narayanan Krishnamurthi', 18)}}的其他基金

Exercise training in Parkinson's disease: Neural and functional benefits
帕金森病的运动训练:对神经和功能的益处
  • 批准号:
    8079996
  • 财政年份:
    2010
  • 资助金额:
    $ 28.75万
  • 项目类别:
Exercise training in Parkinson's disease: Neural and functional benefits
帕金森病的运动训练:对神经和功能的益处
  • 批准号:
    7690886
  • 财政年份:
    2008
  • 资助金额:
    $ 28.75万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 28.75万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 28.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 28.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 28.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 28.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 28.75万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 28.75万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 28.75万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 28.75万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 28.75万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了